Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

LI-COR now offers contract manufacturing for early-phase cGMP materials
September 2016
SHARING OPTIONS:

LINCOLN, Neb.—Building on its expertise in reagent and dye production, LI-COR is expanding its services to include synthesis and conjugation services for early-phase cGMP production, the company reported in late August.
 
“We offer a variety of custom services and can apply our unique expertise in dye and probe development for intra-operative surgery to help researchers,” says Bambi Reynolds, senior business development manager. “We have expanded our production facility to accommodate contract manufacturing for both preclinical and early-phase clinical applications.”
 
LI-COR offers development and manufacturing of dyes and small molecules, including custom derivatives of fluorescent dyes and active pharmaceutical ingredients.
 
“Our clients in need of dye-conjugated biomolecules are able to benefit from our extensive experience in biology and chemistry services that we have developed for our instrumentation platforms,” said Reynolds.
 
LI-COR touts itself as a pioneer in the use of near-infrared (NIR) technology as a detection method. In the early 1990s LI-COR introduced NIR DNA sequencing technology that has led to other preclinical applications including protein and small animal imaging using NIR. This preclinical development has led to two near-infrared dyes being translated into the clinical trials using targeted NIR as a method for both detection and treatment of various types of cancer.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.